NCT01109303

Brief Summary

Ankle fracture is frequent and its number is increasing. In Canada, surgical treatment of these lesions is advised and the options currently used all have in common a rigid fixation of the syndesmosis which results in residual stiffness and a high level of secondary surgery, mostly to remove the implant. The purpose of the study is to compare the treatment of ankle syndesmotic rupture by a dynamic fixation to a static fixation suggesting that the dynamic fixation method will improve the Olerud-Molander functional score of more than 15 points at the 3 months follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 23, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
Last Updated

December 20, 2012

Status Verified

December 1, 2012

Enrollment Period

2.3 years

First QC Date

April 21, 2010

Last Update Submit

December 19, 2012

Conditions

Keywords

ankle fracture with syndesmotic ligament ruptureankle syndesmosis rupture

Outcome Measures

Primary Outcomes (1)

  • Olerud-Molander score

    The Olerud-Molander scoring scale was chosen because it adequately represents the ankle performance following surgery (trauma or elective basis). It comprises nine functional parameters which are concerned with primary complaints, the ability to perform simple tasks and the everyday life activities.

    3 months after surgery

Secondary Outcomes (23)

  • Rate of secondary surgery

    within one year following surgery

  • Radiological loss of reduction

    2 weeks after surgery

  • Implant failure

    one year after surgery

  • Radiological loss of reduction

    6 weeks after surgery

  • Radiological loss of reduction

    12 weeks after surgery

  • +18 more secondary outcomes

Study Arms (2)

TightRope System

ACTIVE COMPARATOR

Patients are operated on using the TightRope implant by Arthrex.

Procedure: TightRope System- Arthrex® / Dynamic Implant

Screw fixation implant

ACTIVE COMPARATOR

Patients are operated on using the rigid four-cortices 3,5 mm screw fixation by Synthes.

Procedure: Screw fixation - Synthes® / Static Implant

Interventions

Patients are operated on using a dynamic implant, the TightRope System by Arthrex®. The ankle is immobilized in a plaster boot for 6 weeks.

TightRope System

Patients are operated on using a static implant, the rigid four-cortices 3,5 mm screw fixation by Synthes®. The ankle is immobilized in a plaster boot for 6 weeks.

Screw fixation implant

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • men or women ≥ 18 years-old;
  • ankle fracture type 44-C (AO classification) with an AP, lateral and mortise X-ray views of the ankle and an AP and lateral X-ray views of the leg;
  • open fractures (Gustilo I-IIIb) or closed;
  • trauma-surgery delay of less than 7 days;
  • consent form signed.

You may not qualify if:

  • ankle fractures without syndesmotic lesion;
  • fracture associated with neuro-vascular lesions (Gustillo IIIc);
  • pathologic fracture;
  • fracture in a polytraumatized patient;
  • fracture of a bone in the ipsilateral leg;
  • men or women \> 65 years-old;
  • chronic cardiac insufficiency (ejection fraction \< 30%);
  • lower leg chronic venous insufficiency;
  • neuro-arthropathic foot (Charcot, diabetes, etc…);
  • body mass index ≥ 40;
  • past medical history of fracture of the same ankle;
  • medical conditions too serious for a surgery;
  • men or women unfit to consent;
  • any other conditions that make the examinator thinks that the follow up would be problematic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHA-Pavillon Enfant-Jésus

Québec, Quebec, G1J 1Z4, Canada

Location

Study Officials

  • Stéphane Pelet, MD, PhD

    Hôpital Enfant-Jésus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Stephane Pelet MD, PhD Orthopedic surgeon

Study Record Dates

First Submitted

April 21, 2010

First Posted

April 23, 2010

Study Start

October 1, 2008

Primary Completion

February 1, 2011

Study Completion

January 1, 2012

Last Updated

December 20, 2012

Record last verified: 2012-12

Locations